I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Blauvelt, A
1041
results:
Online X
Search for persons
X
Format
Online (1041)
Mediatypes
E-Books (15)
Articles (Online) (693)
Bookchapter (Online) (51)
OpenAccess-fulltext (282)
Languages
english (791)
german (5)
more...
french (28)
spanish (2)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Optimizing maintenance therapy in responders to abrocitinib..:
Thyssen, J. P.
;
Silverberg, J. I.
;
Ruano, J.
...
Journal of the European Academy of Dermatology and Venereology. , 2024
Link:
https://doi.org/10.1111/..
?
2
P1081 Pharmacokinetics and immunogenicity of the ustekinuma..:
Chow, V
;
Mytych, D T
;
Blauvelt, A
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1943-i1943 , 2024
Link:
https://doi.org/10.1093/..
?
3
CO230 Efficacy and Safety of Roflumilast Foam 0.3% in Patie..:
Blauvelt, A.
;
Draelos, Z.D.
;
Gooderham, M.
...
Value in Health. 26 (2023) 6 - p. S59 , 2023
Link:
https://doi.org/10.1016/..
?
4
ONCE-DAILY ROFLUMILAST CREAM 0.15% FOR ATOPIC DERMATITIS: P..:
Eichenfield, L.
;
Boguniewicz, M.
;
Simpson, E.
...
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S91 , 2023
Link:
https://doi.org/10.1016/..
?
5
RUXOLITINIB CREAM DEMONSTRATES DURABLE LONG-TERM DISEASE CO..:
Geng, B.
;
Eichenfield, L.
;
Kircik, L.
...
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S13 , 2023
Link:
https://doi.org/10.1016/..
?
6
Efficacité de l'upadacitinib versus dupilumab dans la derma..:
Blauvelt, A.
;
Silverberg, J.I.
;
Eyerich, K.
...
Revue Française d'Allergologie. 63 (2023) 3 - p. 103606 , 2023
Link:
https://doi.org/10.1016/..
?
7
Bimekizumab speed of response in patients with moderate to ..:
Blauvelt, A
;
Duffin, KC
;
Magnolo, N
...
SKIN The Journal of Cutaneous Medicine. 6 (2022) 6 - p. s69 , 2022
Link:
https://doi.org/10.25251..
?
8
LONG-TERM SAFETY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC D..:
Blauvelt, A.
;
Eichenfield, L.
;
Sierka, D.
...
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S19 , 2022
Link:
https://doi.org/10.1016/..
?
9
MEANINGFUL RESPONSES IN TRALOKINUMAB-TREATED ADOLESCENTS WI..:
Paller, A.
;
Blauvelt, A.
;
Soong, W.
...
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S74 , 2022
Link:
https://doi.org/10.1016/..
?
10
Dupilumab provides long-term efficacy for up to 4 years in ..:
Blauvelt, A.
;
Thyssen, J.P.
;
Lockshin, B.
...
Revue Française d'Allergologie. 62 (2022) 3 - p. 321 , 2022
Link:
https://doi.org/10.1016/..
?
11
Super‐response to guselkumab treatment in patients with mod..:
Reich, K.
;
Gordon, K.B.
;
Strober, B.
...
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 12 - p. 2393-2400 , 2022
Link:
https://doi.org/10.1111/..
?
12
Maintenance of bimekizumab efficacy through 2 years in pati..:
Thaçi, D
;
Armstrong, A
;
Lebwohl, M
...
SKIN The Journal of Cutaneous Medicine. 6 (2022) 6 - p. s71 , 2022
Link:
https://doi.org/10.25251..
?
13
Durability of DLQI Improvements Among Patients with Moderat..:
Blauvelt, A
;
Warren, RB
;
Reich, K
...
SKIN The Journal of Cutaneous Medicine. 5 (2021) 1 - p. s19 , 2021
Link:
https://doi.org/10.25251..
?
14
Bimekizumab Efficacy and Safety versus Adalimumab in Patien..:
Warren, RB
;
Blauvelt, A
;
Bagel, J
...
SKIN The Journal of Cutaneous Medicine. 5 (2021) 1 - p. s15 , 2021
Link:
https://doi.org/10.25251..
?
15
Long-Term Improvements in Health-Related Quality of Life of..:
Thaçi, D
;
Blauvelt, A
;
Reich, K
...
SKIN The Journal of Cutaneous Medicine. 5 (2021) 1 - p. s20 , 2021
Link:
https://doi.org/10.25251..
1-15